TASER Wireless eXtended Range Electronic Projectile (XREP) Successfully Deployed
to Save Woman's Life
SCOTTSDALE, Ariz., Nov. 6, 2009 (GLOBE NEWSWIRE) -- TASER International, Inc.
(Nasdaq:TASR), a market leader in digital evidence solutions and electronic
control devices (ECDs), announced that on November 4 the Waukesha Police
Department in Wisconsin successfully deployed the TASER(R) eXtended Range
Electronic Projectile (XREP(TM)) from a TASER(R) X12(TM) Less Lethal Shotgun
(LLS) to subdue a suicidal woman.
According to Waukesha Police, officers responded to a report of a suicidal woman
with a knife. She was not only threatening her own life, but the life of
another. Upon arrival officers received information that the subject of the call
was a 47-year-old woman with a history of mental illness.
Officers located the woman in a highly agitated state. In order to safely take
her into protective custody officers deployed the XREP. The deployment was
successful and no higher forms of force were needed. Neither the woman nor any
officers were injured.
"This is a momentous event for our law enforcement partners as this is the first
life protected without injury outside of our pilot programs through the combined
use of our production advanced wireless TASER XREP and our TASER X12 Less Lethal
Shotgun," said Tom Smith, Chairman and founder of TASER International. "We are
pleased with the performance of these two life-saving systems integrating
successfully. We applaud the Waukesha Police Department's successful
intervention to protect life with TASER technology."
About TASER XREP and TASER X12
The XREP is a wireless self-contained electronic ECD deployed from a 12-gauge
pump-action. It delivers a similar Neuro Muscular Incapacitation (NMI)
bio-effect as our handheld TASER(R) X26(TM) ECD with a maximum effective range
approaching 100 feet (30.48 meters).
The battery supply is fully integrated into the chassis and provides the power
to drive the XREP projectile engine and thereby "wireless" compared to
traditional hand held TASER ECDs.
While the XREP can be deployed from any 12-gauge pump-action shotgun, Mossberg
and TASER International joined forces to produce the TASER(R) X12(TM) LLS,
utilizing a re-engineered Mossberg 500 pump-action shotgun to optimize the TASER
XREP. The TASER X12 includes Radial Key(TM) Ammunition technology to prevent the
system from deploying lethal 12-gauge rounds in order to remove the possibility
of end users accidentally firing a lethal round in a less-lethal system during
high stress situations.
No other system on the market today prevents the operator from inadvertently
deploying a lethal round. In addition, it incorporates a uniquely designed
twist, rifled barrel that optimizes the performance of the XREP, ensuring that
an optimum spin rate is imparted upon the projectile as it exits the barrel to
ensure the greatest distance, stabilization, and accuracy possible.
For more information about the XREP and X12 systems visit:
http://www.taser.com/products/law/Pages/TASERXREP.aspx
http://www.taser.com/products/law/Pages/TASERX12.aspx
About TASER International, Inc.
TASER International's products Protect Life and Protect Truth. TASER provides
advanced Electronic Control Devices (ECDs) and innovative secured digital
evidence collection and management solutions for use in the law enforcement,
medical, military, corrections, professional security, and personal safety
markets. TASER ECDs use proprietary technology to incapacitate dangerous,
combative, or high-risk subjects who pose a risk to law enforcement officers,
innocent citizens, or themselves in a manner that is generally recognized as a
safer alternative to other uses of force. The TASER(R) AXON(TM), a revolutionary
on-officer tactical computer and video/audio recorder, combines with an
integrated digital multi-media evidence storage and management platform --
EVIDENCE.COM -- to provide an end-to-end solution to capture, store securely,
and analyze digital evidence and information in ways that enables tactical and
strategic decision making by law enforcement, as well as for legal evidentiary
use. For more information please call TASER International at (800) 978-2737 or
visit our website at www.TASER.com.
The TASER International logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=2931
Note to Investors
This press release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended (the "Securities Act"),
and Section 21E of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), including statements, without limitation, regarding our
expectations, beliefs, intentions or strategies regarding the future. We intend
that such forward-looking statements be subject to the safe-harbor provided by
the Private Securities Litigation Reform Act of 1995. The forward-looking
information is based upon current information and expectations regarding TASER
International. These estimates and statements speak only as of the date on which
they are made, are not guarantees of future performance, and involve certain
risks, uncertainties and assumptions that are difficult to predict. Therefore,
actual outcomes and results could materially differ from what is expressed,
implied, or forecasted in such forward-looking statements.
TASER International assumes no obligation to update the information contained in
this press release. These statements are qualified by important factors that
could cause our actual results to differ materially from those reflected by the
forward-looking statements. Such factors include but are not limited to: (1)
market acceptance of our products; (2) our ability to establish and expand
direct and indirect distribution channels; (3) our ability to attract and retain
the endorsement of key opinion-leaders in the law enforcement community; (4) the
level of product technology and price competition for our products; (5) the
degree and rate of growth of the markets in which we compete and the
accompanying demand for our products; (6) risks associated with rapid
technological change and new product introductions; (7) competition; (8)
litigation including lawsuits resulting from alleged product related injuries
and death; (9) media publicity concerning allegations of deaths and injuries
occurring after use of the TASER device and the negative effect this publicity
could have on our sales; (10) TASER device tests and reports; (11) product
quality; (12) implementation of manufacturing automation; (13) potential
fluctuations in our quarterly operating results; (14) financial and budgetary
constraints of prospects and customers; (15) order delays; (16) dependence upon
sole and limited source suppliers; (17) negative reports concerning the TASER
device; (18) fluctuations in component pricing; (19) government regulations and
inquiries; (20) dependence upon key employees and our ability to retain
employees; (21) execution and implementation risks of new technology; (22)
ramping manufacturing production to meet demand; (23) medical and safety
studies; (24) field test results; and (25) other factors detailed in our filings
with the Securities and Exchange Commission, including, without limitation,
those factors detailed in the Company's Annual Report on Form 10-K and its Form
10-Qs.
The statements made herein are independent statements of TASER International.
The inclusion of any third parties does not represent an endorsement of any
TASER International products or services by any such third parties.
-0-
CONTACT: TASER International, Inc.
Steve Tuttle, Vice President of Communications
Media ONLY Hotline: (480) 444-4000
